Position in ABBV
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,552,870
+$562,856 QoQ
Shares Held
6,171
+35.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#2,148
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Opal Wealth Advisors, LLC holds $5,257,340 across 8 Drug Manufacturers - General names. ABBV ranks #1 (29.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
6,171 | $1,552,870 | |
| 2 | LLY |
ELI LILLY & Co
|
786 | $942,752 | |
| 3 | NVS |
Novartis AG
|
4,383 | $686,903 | |
| 4 | JNJ |
Johnson & Johnson
|
2,037 | $517,336 | |
| 5 | AMGN |
Amgen Inc
|
1,394 | $504,795 | |
| 6 | AZN |
Astrazeneca PLC
|
2,227 | $422,283 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,998 | $385,243 | |
| 8 | PFE |
Pfizer Inc
|
10,181 | $245,158 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,552,870 | 6,171 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $990,014 | 4,552 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $1,059,508 | 4,637 | Shares | Sole | 2026-01-26 | |
| 2025-09-30 | $1,067,167 | 4,609 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $918,819 | 4,950 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,114,855 | 5,321 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $930,259 | 5,235 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $1,023,341 | 5,182 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $886,929 | 5,171 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $921,608 | 5,061 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $902,080 | 5,821 | Shares | Sole | 2024-01-22 | |
| 2023-09-30 | $1,011,819 | 6,788 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $904,038 | 6,710 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $972,316 | 6,101 | Shares | Sole | 2023-04-19 | |
| 2022-12-31 | $865,259 | 5,354 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $703,126 | 5,239 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $753,087 | 4,917 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $785,909 | 4,848 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $652,763 | 4,821 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $499,438 | 4,630 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $539,996 | 4,794 | Shares | Sole | 2021-08-02 | |
| 2021-03-31 | $492,076 | 4,547 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $469,209 | 4,379 | Shares | Sole | 2021-02-11 | |
| No filing history on record for this holder in this stock. | ||||||